Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

. . . Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update August 14, 2024 5:00 PM EDT | Source: Phio Pharmaceuticals Corp. Marlborough, Massachusetts--(Newsfile Corp. - August 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the quarter ended June 30, ...